VicE PRESidEnt 2009-2011
Christy Chuang-Stein
I
accepted the nomination to run for ASA vice president with 5. Support the activities of the ASA’s Section on Statistical Education. I am fully
excitement and pride. Excited that I might have a chance behind the ongoing ASA initiatives in connecting with pre-college teachers and
to serve our great profession in a highly influential capacity fostering interest in a career in statistics among undergraduates. I would also
and proud that others have recognized my ability to do the like to work with graduate programs in statistics to prepare students in their
job well. communications and nontechnical skills. The latter, in my opinion, are critical to
Throughout my 28-year career in academia and industry,
the effectiveness and success of our statisticians in the modern world.
I have come to love the statistical profession and appreciate I will be honored to serve the ASA and its members as vice president. I will give it
christy
chuang-Stein
the impact the ASA has made on the society in the United my best effort if given this unique opportunity.
States. Recent efforts to enhance the association’s future in
Present Position: Executive Director, Statistical Research and Consulting
traditional areas of strength and to expand the scope of the ASA’s influence in
Center, Pfizer Inc.
science policy will bring further credibility to the association. Ongoing activi-
ties to influence K-12 education, to facilitate distance learning, and to attend to
Former Positions: Site Head, Midwest Statistics, Pfizer; Director of Statistical
member’s professional development will help secure the future of the statistical
and Programming, Michigan, Pharmacia and Upjohn Company
profession, and therefore that of the ASA.
Degrees: PhD, Statistics, University of Minnesota (1980); BS, Mathematics,
If elected, I would like to focus on the community aspects of the ASA. This comes
National Taiwan University (1975)
from my strong desire for the ASA to be the kind of association with which its
Fields of Major Statistical Activities: Adaptive designs, benefit-risk assessment,
members have a strong rapport and in which its members take great pride. The
multiregional trials, on-the-job training of statisticians, multiple co-primary
areas of particular interest to me are:
endpoints, noninferiority trials, phase III success probability, safety evaluations
1. Inspire a strong professional identity and professional pride. I would like to find
Publications: “An Approach to Rationalize Partitioning Sample Size into
ways to share the successful stories of statisticians to inspire members of the ASA.
Individual Regions in a Multiregional Trial,” Drug Information Journal (2008);
Behind every new Fellow, there is a story. Behind every award, there is a statistical
“Measures for Conducting Comparative Benefit: Risk Assessment,” Drug
ambassador. If we collectively take pride in what we do, we’ll be able to put a
Information Journal (2008); “Challenge of Multiple Co-Primary Endpoints: A
touch of glory in our lives and bring our profession to an even higher level.
New Approach,” Statistics in Medicine (2007); “Sample Size and the Probability
2. Encourage professional service. The health of a profession depends critically
of a Successful Trial,” Pharmaceutical Statistics (2006); “Sample Size Re-
on the full engagement of its members. Engagement means participating in the
Estimation: A Review and Recommendations,” Drug Information Journal
activities, better yet, leading the activities. To have a vibrant organization, we must
(2006); Analysis of Clinical Trials Using SAS: A Practical Guide (2005); “Recent
first have vibrant members who strive to find a solution instead of finding fault. I
Advancement in the Analysis and Presentation of Safety Data,” Drug Information
would like to work closely with the ASA’s Special Interest Group on Volunteerism
Journal (2001); other publications in JASA, Controlled Clinical Trials, Journal of
to further promote the volunteerism culture and find ways of acknowledging all
Biopharmaceutical Statistics, Biometrical Journals, Statistical Methods in Medical
services, big and small, rendered by the ASA members.
Research, Biopharmaceutical Report, Encyclopedia of Clinical Trials, Encyclopedia of
Biopharmaceutical Statistics, and many medical journals
3. Promote outreach and partnering with other disciplines. I remember the appre-
hensions when computer scientists started developing data-mining algorithms.
ASA Activities and Offices Held: ASA Fellows Committee (2008–2010); Fellow
Similarly, some statisticians feel nervous that bioinformatics scientists are devel-
(1998); Excellence in Continuing Education Award (2005); Program Committee,
oping disease models that incorporate biomarker prediction. Statisticians should
Joint Statistical Meetings (1999); Executive Committee, Biopharmaceutical
not stand by the sidelines; we need to actively reach out and partner with other
Section (1996–1999); President, South-West Michigan Chapter (1997); Chair,
disciplines. We need to think broadly and apply wisely. We need to be ahead of
Biopharmaceutical Annual Workshop (1996–1997); Associate Editor, The
the game in all areas where statistical thinking is central to the scientific pursuit.
American Statistician (1993–1999)
4. Establish a mentoring system. I remember starting as a junior statistician. Many
Related Professional Activities: Chair, Biostatistics and Data Management
statisticians senior or more experienced than I was have guided me and given me
Group of the Pharmaceutical Research and Manufacturers Association of
opportunities to stretch myself. The wisdom and experience generously shared
the Americas (2003–2004); Co-Founding Editor, Pharmaceutical Statistics
with me has greatly helped me grow as a professional. I would like ASA members,
(2002–2005); Editorial Board Member, Pharmaceutical Statistics (2002–Present);
especially the junior members, to feel that the ASA is a family and there is a
Associate Editor, Drug Information Journal (1996–Present); Associate Editor,
mechanism for them to seek guidance from the statistician whom they consider to
Encyclopedia of Clinical Trials (2005–Present); Associate Editor, Journal of
be a role model. I look forward to the ASA implementing Zig Ziglar’s saying that
Biopharmaceutical Statistics (2000–2002); Steering Committee of the Americas
“A lot of people have gone further than they thought they could because someone
of the Drug Information Association (1997–1999); member of several special
else thought they could.”
emphasis panels to review grants submitted to the National Institutes of Health
14 AMSTAT NEWS MARCH 2008
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84